LONDON, September 6, 2012 /PRNewswire/ --
* Prolong is approved in the 31 countries of the European Economic
Area, for Climax Control training as a Class II a medical device.
* Prolong costs [pounds sterling]160 while Psychosexual Therapy
costs [pounds sterling]600-[pounds sterling]800
[R]A newly approved treatment for men experiencing premature
ejaculation (PE) was unveiled at the World Congress of Sexual Medicine
in Chicago on Monday, the 27[sup.th] of August 2012.
Prolong TM is an approved treatment for climax control in Europe,
available on the Internet at http://www.aboutpe.com and in the UK from
SOURCE The London Psychiatry Centre
Creator and Harley Street Psychiatrist Dr Zamar said: < br>
Note to Editors:
Prolong TM was developed in 2008, after independent clinical trials
in London University Teaching Hospitals in 2004, where the prototype in
conjunction with the programme was compared to an active control, the
Gold Standard treatment, rather than a placebo. While there are a number of current treatments
available including Psychosexual Therapy, SSRIs and local anaesthetics,
I realised there was a need for an effective, discreet, side effect free
and affordable treatment that's easy to access.
New PE treatment set to improve the sex lives of millions of men. The
presentation was peer reviewed and was published in the August is sue of
the Journal of Sexual Medicine in the proceedings of the World Meeting
on Sexual Medicine 2012.
* Comparing the effect sizes of Prolong TM with other effective
treatments- Antidepressants have an effect size in the treatment of
depression khasiat herbal hajar jahanam of 0.31, local anaesthetics and antidepressants have an
effect size of between three and six in the treatment of PE, whilst
Prolong has an effect size of 11 for the treatment of PE, making Prolong
TM 2-3.5 times more effective than other treatments for PE.
Dr Andy Zamar presented climax control training device and programme
Prolong TM, which has been found to prolong the time to ejaculation by
an average 11 fold.
The device, to be used in conjunction with the start-stop technique,
is: substantially cheaper than current available treatments fo r PE ;
free from side effects; provides long-term effects; and requires no
prescription or medical consultations.
* Benefits were noted at week one, were maximal at week six and
lasted at least three months after the programme was completed.
"Roughly 30% of men experience premature ejaculation at some
point in their lives. In the trial, 61 per
cent of men reported lasting 11 times longer during intercourse after
using Prolong, compared to three fold improvements in 40 per cent of men
who had undergone Teaching Hospital standard Psychosexual Therapy.
"The independent clinical trials have proven the benefits
Prolong can make to the lives of men and, subsequently, their partners,
s o hopefully the availability of the device will mark the beginning of
the end to the suffering caused by premature ejaculation."
* Based on the expected large effect size of Prolong TM and a study
power of 80% (the globally accepted clinical trial standard), it was
calculated that 52 participants were to be enrolled in the clinical
In light of the clinical trial results, Dr Zamar recommended that
Prolong TM should be the first line treatment for PE as well as used
alongside other treatments, as the programme has no harmful effects